Cargando…
Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
Findings on racial differences in survival in multiple myeloma (MM) have been inconclusive. We assessed differences in outcomes between White and Black individuals among 639 newly diagnosed MM patients in the MM Research Foundation CoMMpass registry with baseline cytogenetic data. Survival curves we...
Autores principales: | Derman, Benjamin A., Jasielec, Jagoda, Langerman, Spencer S., Zhang, Wei, Jakubowiak, Andrzej J., Chiu, Brian C.-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414120/ https://www.ncbi.nlm.nih.gov/pubmed/32770051 http://dx.doi.org/10.1038/s41408-020-00347-6 |
Ejemplares similares
-
Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022) -
Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone with and without daratumumab in relapsed multiple myeloma
por: Derman, Benjamin A., et al.
Publicado: (2023) -
Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation
por: Derman, Benjamin A., et al.
Publicado: (2021) -
Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma
por: Chiu, Brian C.-H., et al.
Publicado: (2022) -
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma
por: Derman, Benjamin A., et al.
Publicado: (2022)